Background and Aim: Nuclear factor kappa B (NF-κB) activation and endoplasmic reticulum (ER) stress signaling play significant roles in the pathogenesis of inflammatory bowel disease (IBD). Thus, we evaluated whether new therapeutic probiotics have anticolitic effects, and we investigated their mechanisms related to NF-κB and ER-stress pathways. Methods: Luciferase, nitric oxide, and cytokine assays using HT-29 or RAW264.7 cells were conducted. Mouse colitis was induced using dextran sulfate sodium and confirmed by disease activity index and histology. Macrophages and T-cell subsets in isolated peritoneal cavity cells and splenocytes were analyzed by flow cytometry. Gene and cytokine expression profiles were determined using reverse-transcription polymerase chain reaction. Results: Lactobacillus acidophilus (LA1) and Pediococcus pentosaceus inhibited nitric oxide production in RAW264.7 cells, but only LA1 inhibited Tnfa and induced Il10 expression. LA1 increased the lifespan of dextran sulfate sodium-treated mice and attenuated the severity of colitis by inducing M2 macrophages in peritoneal cavity cells and Th2 and Treg cells in splenocytes. The restoration of goblet cells in the colon was accompanied by the induction of Il10 expression and the suppression of pro-inflammatory cytokines. Additionally, we found that LA1 exerts an anti-colitic effect by improving ER stress in HT-29 cells as well as in vivo. Conclusions: We showed that LA1 significantly interferes with ER stress and suppresses NF-κB activation. Our findings suggest that LA1 can be used as a potent immunomodulator in IBD treatment, and the regulation of ER stress may have significant implications in treating IBD.
Introduction
Inflammatory bowel disease (IBD) is a chronic relapsing disorder of the gastrointestinal tract of unknown causes. 1 In spite of various pharmaceutical treatments for IBD, 2 current therapeutic agents are only moderately effective and have potential side effects including toxicity and higher risk of infectious complications. 3 These aspects emphasize the need for other therapeutic options. Although the pathogenesis of IBD is not completely elucidated, it is currently widely accepted that IBD involves disruption of the homeostasis between the gut microbiota and the mucosal immune system. 4 Probiotics as live microorganisms can modulate the gut microbial composition, improve abnormal mucosal immune responses to chronic intestinal inflammation, and tighten the gut barrier function through their impact on cytokine production, induction of regulatory T-cells, microbial killing, and intestinal cell survival. 5 Apart from their health benefits, probiotics are relatively cheap and have good long-term safety profiles. However, the mechanism underlying their health effects is not fully understood. 6 Chronic inflammation leads to the activation of toll-like receptors (TLRs) that are expressed by immune cells and non-immune cells, including epithelial cells, and can trigger the overproduction of inflammatory cytokines and endoplasmic reticulum (ER) stress through the activation of nuclear factor kappa B (NF-κB). 7 NF-κB is considered a key regulator of inflammation, 8 and the NF-κB signaling cascade results in the expression of the proinflammatory cytokines and tumor necrosis factor alpha (TNF-α) and the production of nitric oxide (NO), which are hallmarks of IBD. Inflammation-driven ER stress responses are known to aggravate intestinal inflammation, which can worsen IBD. 9, 10 In addition, IBD has been associated with variations in the X-boxbinding protein 1 gene (XBP1), which encodes a transcription factor that is activated by ER stress under chronic inflammation. 11 Prolonged ER stress is emerging as an important contributor to IBD pathology. 12 Here, we screened probiotics isolated from a Korean population to evaluate whether they can suppress NF-κB activation and then investigated their mechanisms related to ER-stress pathways.
Materials and methods
Cell culture and treatment. Six probiotic Lactobacillus strains (Lactobacillus acidophilus LA1, Lactobacillus casei LC5, Lactobacillus paracasei LPC5, Lactobacillus plantarum LP3, Lactobacillus reuteri LU4, Lactobacillus rhamnosus LR5), five Bifidobacterium strains (Bifidobacterium bifidum BF3, Bifidobacterium breve BR3, Bifidobacterium longum subsp. infantis BT1, Bifidobacterium lactis BL3, Bifidobacterium longum BG7), two Enterococcus strains (Enterococcus faecalis EFL2, Enterococcus faecium EF4), and three butyrate-producing bacteria (Eubacterium hallii SL6, Pediococcus pentosaceus SL4 and Lactococcus lactis ST3), all of which were isolated from Korean populations, were kindly provided by Cell Biotech (Gimpo, Korea). Selected bacteria for in vivo experiments were cultured in Luria-Bertani broth in a 37°C incubator and re-suspended in sterile phosphate-buffered saline (PBS) to optimal concentration. For in vitro experiments, test cells were incubated in 10% fetal bovine serum-supplemented RPMI medium without antibiotics, with or without lipopolysaccharides (LPS, 1 μg/mL, Sigma-Aldrich, St. Louis, MO, USA) for indicated times after coculture with or without live probiotics (1 × 10 6 cells/mL). The culture media and the cells were collected and frozen at À70°C for later assays. Bay 11-7082 (NF-κB inhibitor), salubrinal (ER-stress inhibitor), and thapsigargin (ER-stress inducer) were purchased from SigmaAldrich.
Transfection, luciferase assays, nitric oxide assay, quantitative reverse-transcription polymerase chain reaction, flow cytometry analysis, and cytokine measurement. The detailed methods for transfection, luciferase assays, NO assay, quantitative reverse-transcription polymerase chain reaction (qRT-PCR), flow cytometry analysis, and cytokine measurement are described in Supporting Information.
Experimental colitic mouse studies. The detailed methods for dextran sodium sulfate (DSS)-induced colitis in mice are described in Supporting Information. All experiments using animals were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Yonsei University Severance Hospital, Seoul, Korea (IACUC Approval No: 2015-0407) and were carried out in accordance with the guidelines of the IACUC.
Periodic acid-Schiff staining, histology, and isolation of lymphocytes from the spleen. The detailed methods for periodic acid-Schiff (PAS) staining, histology, and isolation of lymphocytes from the spleen are described in Supporting Information.
Statistical analysis. GraphPad Software (La Jolla, CA, USA) was used for statistical analyses. The significance of differences between conditions was assessed using Student's t-test or one-way analysis of variance. Data were given as the mean ± SD. P values <0.05 were considered significant.
Results
Probiotics suppressing nuclear factor kappa B activation induce different immune responses in intestinal epithelial cells and in macrophages. Nuclear factor kappa B activation has been shown to be essential for the induction of most cytokine genes in inflammatory responses, 13 in both intestinal epithelial cells (IECs) and innate immune cells. It plays significant roles in maintaining intestinal homeostatic functions. Therefore, to select probiotics effectively suppressing NF-κB activation, luciferase vectors containing NF-κ B were transfected into HT-29 cells, human IECs, and the cells were cocultured with 16 live probiotics isolated from Korean subjects (five Bifidobacteria, six Lactobacilli, two Enterococci, one Lactococcus, one Pediococcus, one Streptococcus) and stimulated with LPS. L. acidophilus (LA1) and P. pentosaceus (SL4) showed the strongest suppressive effect on NF-κB transactivation by LPS (Fig. 1a) . Although LPC5 also seemed to suppress NF-κB transactivation, its effect did not reach significance in comparison with the control group. Next, to explore the effects of LA1 and SL4 on macrophage activation, we stimulated RAW264.7 murine macrophages with LPS after pretreatment LA1 or SL4. Then, we measured the amount of NO and representative cytokines (TNF-α and IL-10) produced by the macrophages in the culture media. The NO production by LPS-stimulated macrophages was suppressed by both LA1 and SL4 (Fig. 1b) . Our qRT-PCR analysis showed that LA1 significantly suppressed Tnfa gene expression and induced Il10 compared with LPS-treated groups; however, no difference in Tnfa and Il10 transcript levels was detected after treatment with SL4 (Fig. 1c) .
Lactobacillus acidophilus attenuates mouse colitis by modulating goblet cells and immune cells. To investigate the therapeutic effects of LA1 and SL4 in vivo, colitis was induced in mice by administration of 2.5% DSS in the drinking water. DSS administration to 8-week-old mice induced severe colitis as assessed by a disease activity index that takes into account bodyweight loss, stool consistency, and gross bleeding after sacrifice. 14 We found that LA1 prominently improved the survival rates of 6-week-old mice with DSS-induced colitis (Fig. 2a) . LA1 administration significantly restored bodyweight ( Fig. 2b ) and colon length ( Fig. 2c ) and reduced disease activity in DSS-treated mice. However, SL4 did not induce significant changes in survival rate or disease activity ( Fig. 2b-d ). Integral colonic epithelium and no inflammatory cell infiltration were observed in the colons from the negative control mice, whereas DSS treatment showed extensive microscopic damage to the colon structure, including transmural inflammation with thickening of the muscularis, inflammatory cell infiltration, and significant loss of crypts and goblet cells in the colon, indicating severe disease. These results were confirmed by histological scoring after PAS staining. In contrast, mice receiving LA1 displayed a significant improvement in colonic histopathology compared with DSS colitic mice receiving PBS or SL4. In particular, LA1-treated mice had dramatically enhanced goblet cell numbers ( Fig. 2f) and mRNA expression of mucin 2 (Muc2) and Krüppel-like factor 4 (Klf4), encoding a critical modulator of goblet cells (Fig. 2g) , in the colon.
Inflammation is associated with various inflammatory mediators. To examine whether the probiotics act systemically on M2 polarization of macrophages and T-cell differentiation, we analyzed the M1 (TLR4 + or TREM-1 + ) and M2 (CD206 + ) populations in macrophages (F4/80 + ) from peritoneal cavity cells (PCCs) and the Treg (Foxp3 + ) and Th2 (Gata3 + ) populations in splenic T-cells (CD4 + ) using flow cytometry, given that immune cells play a crucial role in the pathogenesis of colitis. Mice receiving PBS had a significantly decreased F4/80 + CD206 + population in PCCs and CD4 + FOXP3 + and CD4 + GATA3 + in splenocytes, but increased TLR4 and TREM-1 expression in the F4/80 + population of PCCs. In contrast, the LA1-treated mice showed an increase in the number of CD206 + macrophages (Fig. 3a) but decreased TLR4 and TREM-1 expression in macrophages (Fig. 3b) of PCCs, accompanied with increased Foxp3 + and Gata3 + CD4 + cells in splenocytes (Fig. 3c ) compared with DSS-treated or SL4-treated groups. As expected from our in vitro experiments, both LA1-treated and SL4-treated groups showed decreased mRNA expression of iNOS, encoding an NO-producing enzyme in colon tissues. However, only LA1 significantly suppressed the expression of pro-inflammatory cytokine genes such as Tnfa, Il1b, and Il17 in the colon tissues ( Fig. 3e) and increased the expression of Il10 (Fig. 3f) , while SL4-treated mice showed no differences compared with control animals. Taken together, although both LA1 and SL4 suppressed NF-κB and NO production, they had different mechanisms in regulating mucus and cytokine production by modulating epithelial cells and macrophages, respectively.
Lactobacillus acidophilus improves endoplasmic reticulum-stress in intestinal inflammation. Goblet cells are particularly sensitive to ER stress, 15 and the production of multiple pro-inflammatory molecules is associated with ER stress-induced unfolded protein response (UPR) signaling. 16 Previous studies have indicated that ER stress can promote several inflammatory signaling pathways, including NO and reactive oxygen species (ROS) production, the NF-κB pathway, and inflammasome. 17 We identified that LA1 dramatically facilitated goblet cell restoration and induced IL-10, which can be affected by ER stress in IECs. 18 Hence, we investigated whether the anti-colitic effect of LA1 was associated with a downregulation of molecular features of ER stress in the colon tissues. Glucose- regulated protein (Grp78) and C/EBP homologous protein (Chop) gene expression controlled by the ER-stress sensors activating transcription factor 6 (ATF6) and protein kinase RNA (PKR)-like ER kinase (PERK), and XBP-1 mRNA splicing typically are upregulated by UPR signaling, indicating the presence of ER stress. 19 Colonic gene expression of Grp78, Xbp1, and Chop was significantly suppressed in LA1-treated as compared with PBStreated or SL4-treated mice (Fig. 4a) . To confirm our findings in vivo, we investigated the effects of LA1 on gene expression of GRP78, Xbp1, and CHOP in HT-29 IECs treated with thapsigargin, an ER-stress inducer, or salubrinal, an ER-stress inhibitor, with or without Bay 11-7082, an NF-κB inhibitor, using qRT-PCR. Thapsigargin treatment induced the UPR, as indicated by an elevation in the transcript levels of Grp78 and Chop, and Xbp1 splice form (Xbp1s). Similar to our observation in DSSinduced colitis, LA1 significantly suppressed the gene expression of Xbp1s, Grp78, and Chop and protein expression (GRP78 and XBP1) compared with the vehicle (Fig. 4b,c) . Of note, NF-κB inhibitor did not effectively suppress GRP78 and XBP1 when compared with LA1. This result suggests that the suppression of NF-κB signaling is not sufficient for complete suppression of ER stress as shown in a previous study. 18 Together, these results indicate that LA1 reduces ER stress through both NF-κB-dependent and NF-κB-independent pathways.
Discussion
Although several probiotic strains might have positive effects on IBD, conflicting results have been observed in clinical application of probiotics. 20 There are several studies on the mechanisms of anti-inflammatory effects of probiotics, 21, 22 in which probiotics suppressed both NF-κB activation and inflammatory cytokine expression in colitic mice. Activation of the pro-inflammatory NF-κB pathway is thought to be a key molecular event in the pathogenesis of IBD. 23 NO, mainly produced by iNOS activity in activated macrophages, is a potent pro-inflammatory mediator that is detrimental to tissues. 24 iNOS expression is primarily induced by activation of the transcription factor NF-κB in response to proinflammatory cytokines and various bacterial components. Lactobacillus acidophilus (LA1) strain has bile tolerance to be resistant to physiological conditions, which enable the strain to survive, and offers therapeutic benefits in the intestine as candidates of probiotics. 25 We showed that both LA1 and SL4 (P. pentosaceus) consistently suppressed NF-κB activation in IECs, NO production Figure 2 Lactobacillus acidophilus effectively increases the lifespan of DSS-treated mice and attenuates colitis. Probiotics-treated mice given 1 × 10 8 bacteria in 0.1 mL PBS daily by gavage for 7 days from day 6. (a) Survival rates. Six-week-old male C57BL/6 mice were administrated 2.5% dextran sodium sulfate (DSS) and survival was analyzed using Kaplan-Meier plots for overall survival (n = 6). Survival was compared using a log-rank test. (bÀg) Effects of probiotics treatments on colitis-induced changes. We administrated 2.5% DSS to 8-week-old male C57BL/6 mice and evaluated bodyweight (b), colon length (c), disease activity index (d), histopathology (e), goblet cell loss (f), and mRNA levels of Muc2 and Klf4 (g). Effects of probiotics treatments on colitis-induced changes in intestinal histopathologic features of mice. **P < 0.01 versus Control, ***P < 0.005 versus Control, # P < 0.05 versus DSS + Veh, ## P < 0.01 versus DSS + Veh, ### by macrophages, and colonic iNOs expression. Some components of LA1 such as cell wall-associated polysaccharides, proteins, and lipoteichoic acids could directly inhibit NF-κB activation in human HT-29 cells. 26 LA1 can also inhibit the NF-κB activation by secreted metabolites, 27 cell wall components, bacterial DNA, and bacteria-secreted soluble unknown factors 28 that can be mediated by upregulating the negative regulators of TLR signaling 29 or downregulating TLR. 30 A recent study suggested that NF-κB activation might be indirectly suppressed by resolving ER stress by IL-10.
18,31,32 However, P. pentosaceus, a probiotic candidate strain isolated from fermented food, [33] [34] [35] induced no noticeable resolution of colitis compared with L. acidophilus and failed to alleviate ER stress, in spite of its suppressive effect on NF-κB transactivation. These studies suggested that NF-κB-suppressive capacity is not sufficient to inhibit colitis and that there are more pivotal factors, such as the ER-stress pathway.
ER stress and UPR activation are known to be significant mechanisms of chronic intestinal inflammation and are considered potential therapeutic targets. 36 Despite the fact that ER-stress suppression was mediated by NF-κB, 7 only LA1 significantly inhibited Tnfa expression and increased Il10, previously shown to be linked to ER stress, 37 in macrophages. In addition, LA1 increased the number of M2 macrophages in PCCs and Th2 and Treg cells in splenocytes secreting IL-10 in colitic mice. It is well known that a deficient Treg response contributes to IBD. IL-10 protects against TNF-α, a crucial pro-inflammatory cytokine, 18 and controls chronic intestinal inflammation. 38 IL-10 deficiency accompanied with intestinal ER stress leads to the development of severe colitis. 9, 18 In addition, resolution of ER stress by IL-10 can induce M2 macrophage polarization and Th2 differentiation. 31, 32 Previous studies have shown that some probiotics can induce IL-10 production in colitis. 39, 40 In this context, there is some evidence that L. acidophilus can ameliorate colitis by increasing Tregs in the colonic tissues, 41 and moreover, L. acidophilus is significantly reduced in patients with IBD. 42 Here, we showed not only the anti-inflammatory activity of L. acidophilus but also its mechanisms in suppressing ER stress as well as NF-κ B transactivation, which may be critical in the suppression of goblet cell loss and pro-inflammatory cytokines. Our data showed that the anti-colitic effect of L. acidophilus is mediated by regulation of the differentiation of goblet cells, CD4 + T subsets, and cytokine expression through induction of IL-10 and suppression of ER stress. Accordingly, ER-stress inhibitors have been shown to ameliorate various models of colitis in mice. 15 Moreover, Bifidobacteria as well as L. acidophilus showed a beneficial effect on ER stress in vitro.
43 ER-stress suppression in IECs by LA1 was consistent with findings of a previous study in which suppression of ER stress by IL-10 was unaffected by suppression of NF-κB. 18 IL-10 directly suppresses misfolding-induced ER stress in goblet cells and promotes the production of intestinal mucus. 18 Both goblet cells and macrophages play key roles in tissue remodeling in inflammation. 17, 18 UPR-dependent and UPR-independent pathways in goblet cells, mucin-secretory IECs, 19 will lead to depletion of the mucus barrier, increasing microbial exposure. 36 The large, complex intestinal mucin presents a substantial challenge for correct folding in the ER in inflammation. 44 Of note, misfolding of the mucin promotes ER stress, inflammation, and spontaneous colitis. 18 IBD is often characterized by a loss of goblet cells and the consequent reduction in mucus production. 45 In this study, colitic mice had restored goblet cell numbers following LA1 administration, which is consistent with results of a previous study showing the influence of probiotics on mucus production, which probably enhances microbial adherence to the epithelium. 46 Furthermore, diminished XBP1s production was observed after pretreatment of IECs with LA1. The transcription factor XBP1 is a key mediator of ER stress, and XBP1-deficient mice show a loss of secretory Paneth cells and goblet cells in the intestinal epithelium and spontaneous inflammation of the ileum. 11 The suppression of goblet cell loss may be associated with the suppression of ER stress and promotion of Th2 and Treg responses through IL-10 induction. Alternatively, activated (M2) macrophages are considered to have a more substantial role in the resolution of inflammation and tissue repair. 20 Under ER stress, activated inositol-requiring enzyme 1 (IRE1) results in unconventional splicing of the mRNA encoding XBP1, thus generating the spliced form, XBP1s, a potent inducer of a subset of UPR-target genes. 47 Subsequently, GRP78, a chaperone in the ER and the major inducer of the UPR, accumulates with misfolded proteins in the ER, 48 and defective protein folding or disruption of the UPR causes ER stress and spontaneous intestinal inflammation. 49 IL-10 modulates the GRP78 expression levels in IECs, and the lack of IL-10 in chronic inflammatory response may induce tissue pathology in the intestinal mucosa due to the inadequate resolution of ER stress. 9 Overall, LA1 promoted M2 macrophages, Treg cells, and Th2 cells with increased levels of IL-10 and goblet cells in DSS-induced colitic mice, which was correlated with the suppression of ER stress (Fig. 4d) .
In conclusion, we showed that administration of the probiotic L. acidophilus to DSS-treated mice inhibited colitis by goblet cell differentiation and the modulation of immune cells, including M2 macrophages, Th2 cells, and Treg cells, as well as IL-10, which has beneficial effects on ER stress. Additionally, we showed that L. acidophilus can induce goblet cell restoration in IECs as well as suppress NF-κB activation and pro-inflammatory molecule production in macrophages. This is the first study to dissect the mechanisms of L. acidophilus, which can modulate the function of IECs and macrophages in mouse colitis. Furthermore, this study demonstrated that the ER-stress response is a critical driver of colitis, and 
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